Preclinical testing of 3 cysteine-related drugs for reducing dystropathology in the mdx mouse model of Duchenne Muscular Dystrophy

Arthur, Peter (Chief Investigator)
Grounds, Miranda (Investigator 02)

3 Article

3 results

2017
Beneficial effects of high dose taurine treatment in juvenile dystrophic mdx mice are offset by growth restriction
Terrill, J. R., Pinniger, G. J., Nair, K. V., Grounds, M. D. & Arthur, P. G., 1 Nov 2017, In: PLoS One. 12, 11, e0187317.
Research output: Contribution to journal › Article › peer-review

Open Access
13 Citations (Scopus)
2016
Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy
Terrill, J., Duong, M., Turner, R., Le Guiner, C., Boyatzis, A., Kettle, A. J., Grounds, M. & Arthur, P., Oct 2016, In: Redox Biology. 9, p. 276-286 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
25 Citations (Scopus)
2015
Taurine deficiency, synthesis and transport in the mdx mouse model for Duchenne Muscular Dystrophy
Terrill, J., Grounds, M. & Arthur, P., Sep 2015, In: International Journal of Biochemistry and Cell Biology. 66, p. 141-148
Research output: Contribution to journal › Article › peer-review

Open Access
File
32 Citations (Scopus)

311 Downloads (Pure)